tiprankstipranks
Advertisement
Advertisement
Cardiff Oncology Shareholders Approve Directors and Equity Plan
PremiumCompany AnnouncementsCardiff Oncology Shareholders Approve Directors and Equity Plan
1M ago
Campbell, Crescent, Cardiff, Sherwin, Take-Two Trending With Analysts
Premium
Weekend Updates
Campbell, Crescent, Cardiff, Sherwin, Take-Two Trending With Analysts
1M ago
Cardiff Oncology price target lowered to $4 from $10 at Lucid Capital
Premium
The Fly
Cardiff Oncology price target lowered to $4 from $10 at Lucid Capital
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Cardiff Oncology announces results from CRDF-004 trial
Premium
The Fly
Cardiff Oncology announces results from CRDF-004 trial
2M ago
Cardiff Oncology downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Cardiff Oncology downgraded to Neutral from Buy at H.C. Wainwright
2M ago
Cardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
PremiumCompany AnnouncementsCardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
2M ago
Cardiff Oncology Wins Buy Rating on Strong Phase 2 Efficacy, FDA-Aligned Phase 3 Path, and Broader Onvansertib Combination Potential
Premium
Ratings
Cardiff Oncology Wins Buy Rating on Strong Phase 2 Efficacy, FDA-Aligned Phase 3 Path, and Broader Onvansertib Combination Potential
2M ago
Cardiff Oncology reports Q1 EPS (18c), consensus (12c)
Premium
The Fly
Cardiff Oncology reports Q1 EPS (18c), consensus (12c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100